Incidence of and risk factors for severe adverse events in elderly patients taking angiotensin‐converting enzyme inhibitors or Angiotensin II receptor blockers after an …
Study Objective To assess the incidence of and risk factors associated with severe adverse
events in elderly patients who used angiotensin‐converting enzyme inhibitors (ACEI s) or …
events in elderly patients who used angiotensin‐converting enzyme inhibitors (ACEI s) or …
Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers …
G Fang, IE Annis, JF Farley, N Mahendraratnam… - …, 2018 - cdr.lib.unc.edu
Study Objective: To assess the incidence of and risk factors associated with severe adverse
events in elderly patients who used angiotensin-converting enzyme inhibitors (ACEIs) or …
events in elderly patients who used angiotensin-converting enzyme inhibitors (ACEIs) or …
Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers …
G Fang, IE Annis, JF Farley, N Mahendraratnam… - …, 2018 - iro.uiowa.edu
To assess the incidence of and risk factors associated with severe adverse events in elderly
patients who used angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II …
patients who used angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II …
Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers …
G Fang, IE Annis, JF Farley… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Study objective To assess the incidence of and risk factors associated with severe adverse
events in elderly patients who used angiotensin-converting enzyme inhibitors (ACEIs) or …
events in elderly patients who used angiotensin-converting enzyme inhibitors (ACEIs) or …
Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers …
G Fang, IE Annis, JF Farley, N Mahendraratnam… - …, 2017 - europepmc.org
STUDY OBJECTIVE: To assess the incidence of and risk factors associated with severe
adverse events in elderly patients who used angiotensin-converting enzyme inhibitors …
adverse events in elderly patients who used angiotensin-converting enzyme inhibitors …
[HTML][HTML] Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor …
G Fang, IE Annis, JF Farley, N Mahendraratnam… - …, 2018 - ncbi.nlm.nih.gov
Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking
Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute …
Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute …
Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers …
G Fang, IE Annis, JF Farley, N Mahendraratnam… - …, 2018 - experts.umn.edu
Study Objective: To assess the incidence of and risk factors associated with severe adverse
events in elderly patients who used angiotensin-converting enzyme inhibitors (ACEIs) or …
events in elderly patients who used angiotensin-converting enzyme inhibitors (ACEIs) or …
Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers …
G Fang, IE Annis, JF Farley, N Mahendraratnam… - …, 2017 - europepmc.org
STUDY OBJECTIVE: To assess the incidence of and risk factors associated with severe
adverse events in elderly patients who used angiotensin-converting enzyme inhibitors …
adverse events in elderly patients who used angiotensin-converting enzyme inhibitors …
Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers …
G Fang, IE Annis, JF Farley, N Mahendraratnam… - …, 2018 - iro.uiowa.edu
To assess the incidence of and risk factors associated with severe adverse events in elderly
patients who used angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II …
patients who used angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II …